Aftate Triple Antibiotic (Sabel Med LLC)


Welcome to the PulseAid listing for the Aftate Triple Antibiotic drug offered from Sabel Med LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sabel Med LLC
NON-PROPRIETARY NAME: Triple Antibiotic Ointment
SUBSTANCE NAME: POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00


Aftate Triple Antibiotic HUMAN OTC DRUG Details:

Item DescriptionAftate Triple Antibiotic from Sabel Med LLC
LABELER NAME: Sabel Med LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5000; 3.5; 400([iU]/g; mg/g; [iU]/g)
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70356-101_2f6e9a84-895d-492d-e054-00144ff8d46c
PRODUCT NDC: 70356-101
APPLICATION NUMBER: part333B

Other POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chain Drug Marketing Association Inc.Triple Antibiotic
Davemed Healthcare Co., Ltd.Triple Antiobiotic
Lincoln Pharmaceutical Ltd.Lincoln
Sabel Med LLCAftate Triple Antibiotic
Valu Merchandisers, Co.Triple Antibiotic